CUNY-Graduate School of Public Health: Disparities in Mpox Vaccine Uptake Could Leave Many Vulnerable to Resurgence
February 06, 2024
February 06, 2024
NEW YORK, Feb. 6 (TNSres) -- The City University of New York's Graduate School of Public Health and Health Policy issued the following news release:
A study by CUNY SPH researchers found that, even as availability of the mpox vaccine increased toward the end of the 2022 outbreak in the U.S., uptake remained low.
The large-scale study surveyed 8,551 people who identified as sexual and gender minorities and found that by November 2022, when most of the vaccine's availabil . . .
A study by CUNY SPH researchers found that, even as availability of the mpox vaccine increased toward the end of the 2022 outbreak in the U.S., uptake remained low.
The large-scale study surveyed 8,551 people who identified as sexual and gender minorities and found that by November 2022, when most of the vaccine's availabil . . .